Daniel B. Martin

3.9k total citations · 2 hit papers
44 papers, 3.0k citations indexed

About

Daniel B. Martin is a scholar working on Spectroscopy, Molecular Biology and Immunology. According to data from OpenAlex, Daniel B. Martin has authored 44 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Spectroscopy, 17 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Daniel B. Martin's work include Advanced Proteomics Techniques and Applications (24 papers), Mass Spectrometry Techniques and Applications (15 papers) and Metabolomics and Mass Spectrometry Studies (11 papers). Daniel B. Martin is often cited by papers focused on Advanced Proteomics Techniques and Applications (24 papers), Mass Spectrometry Techniques and Applications (15 papers) and Metabolomics and Mass Spectrometry Studies (11 papers). Daniel B. Martin collaborates with scholars based in United States, Switzerland and United Kingdom. Daniel B. Martin's co-authors include Ruedi Aebersold, Jimmy K. Eng, Mark R. Flory, Hookeun Lee, Parag Mallick, Alexey I. Nesvizhskii, Henry Lam, Eric W. Deutsch, David Shteynberg and Jeffrey A. Ranish and has published in prestigious journals such as Journal of Biological Chemistry, Nature Biotechnology and Journal of the American College of Cardiology.

In The Last Decade

Daniel B. Martin

43 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A guided tour of the Trans‐Proteomic Pipeline

2010 601 citations Eric W. Deutsch, Luis Mendoza et al. PROTEOMICS profile →
Computational prediction of proteotypic peptides for quantitative proteomics

2006 551 citations Parag Mallick, Markus Schirle et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel B. Martin United States	28	2.0k	1.5k	268	265	170	44	3.0k
George Rosenberger Switzerland	27	2.8k 1.4×	2.1k 1.4×	272 1.0×	220 0.8×	160 0.9×	36	3.8k
Jason Marchese United States	9	2.7k 1.4×	2.2k 1.4×	258 1.0×	130 0.5×	141 0.8×	12	3.7k
Alexander S. Hebert United States	35	2.8k 1.4×	1.8k 1.2×	268 1.0×	271 1.0×	132 0.8×	67	4.0k
Subhakar Dey United States	9	2.7k 1.4×	2.1k 1.4×	245 0.9×	123 0.5×	142 0.8×	15	3.8k
Derek J. Bailey United States	24	2.8k 1.4×	1.9k 1.3×	240 0.9×	276 1.0×	109 0.6×	32	3.9k
Pedro Navarro Spain	17	3.0k 1.6×	2.2k 1.4×	202 0.8×	188 0.7×	258 1.5×	26	4.3k
Ben C. Collins Switzerland	28	3.0k 1.5×	2.2k 1.4×	290 1.1×	249 0.9×	223 1.3×	54	4.3k
Laurent Gatto Belgium	31	2.1k 1.1×	1.0k 0.7×	357 1.3×	148 0.6×	219 1.3×	75	3.0k
Gregory L. Finney United States	7	2.7k 1.4×	1.4k 0.9×	245 0.9×	188 0.7×	256 1.5×	7	3.9k
Stephen Tate Canada	18	3.0k 1.5×	2.0k 1.3×	435 1.6×	142 0.5×	172 1.0×	30	4.0k

Countries citing papers authored by Daniel B. Martin

Since Specialization

Citations

This map shows the geographic impact of Daniel B. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Martin more than expected).

Fields of papers citing papers by Daniel B. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel B. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Martin. The network helps show where Daniel B. Martin may publish in the future.

Co-authorship network of co-authors of Daniel B. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel B. Martin. A scholar is included among the top collaborators of Daniel B. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel B. Martin. Daniel B. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Daniel B., et al.. (2025). Nocturnal hypertension and cardiovascular events: risk analysis using propensity score matching. Current Problems in Cardiology. 50(12). 103185–103185.

Tuazon, Sherilyn A., Ryan D. Cassaday, Theodore A. Gooley, et al.. (2020). Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma. Transplantation and Cellular Therapy. 27(1). 57.e1–57.e8. 5 indexed citations

Budde, Lihua E., David Wu, Daniel B. Martin, et al.. (2018). Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. British Journal of Haematology. 183(4). 601–607. 7 indexed citations

Zhang, Min, Benjamin L. Prosser, Célio X.C. Santos, et al.. (2015). Contractile Function During Angiotensin-II Activation. Journal of the American College of Cardiology. 66(3). 261–272. 76 indexed citations

Bannow, Bethany Samuelson, et al.. (2015). Use of a computer-based provider order entry (CPOE) intervention to optimize laboratory testing in patients with suspected heparin-induced thrombocytopenia. Thrombosis Research. 136(5). 928–931. 22 indexed citations

Murray, Thomas V., Xuebin Dong, Greta J. Sawyer, et al.. (2015). NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in mice. Free Radical Biology and Medicine. 89. 918–930. 25 indexed citations

Martin, Daniel B., et al.. (2015). Development of a Hematology/Oncology ICD-10 Documentation Job Aid. Journal of the National Comprehensive Cancer Network. 13(4). 435–440. 3 indexed citations

Martin, Daniel B., et al.. (2015). Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency. PubMed. 15(1). 16–16. 29 indexed citations

Margariti, Andriana, Hongling Li, Ting Chen, et al.. (2012). XBP1 mRNA Splicing Triggers an Autophagic Response in Endothelial Cells through BECLIN-1 Transcriptional Activation. Journal of Biological Chemistry. 288(2). 859–872. 232 indexed citations

10.

Holstein, Carly A., Philip R. Gafken, & Daniel B. Martin. (2010). Collision Energy Optimization of b- and y-Ions for Multiple Reaction Monitoring Mass Spectrometry. Journal of Proteome Research. 10(1). 231–240. 35 indexed citations

11.

Deutsch, Eric W., Luis Mendoza, David Shteynberg, et al.. (2010). A guided tour of the Trans‐Proteomic Pipeline. PROTEOMICS. 10(6). 1150–1159. 601 indexed citations breakdown →

12.

Amon, Lynn M., Wendy Law, Matthew Fitzgibbon, et al.. (2010). Integrative Proteomic Analysis of Serum and Peritoneal Fluids Helps Identify Proteins that Are Up-Regulated in Serum of Women with Ovarian Cancer. PLoS ONE. 5(6). e11137–e11137. 30 indexed citations

13.

Martin, Daniel B., Ted Holzman, Damon May, et al.. (2008). MRMer, an Interactive Open Source and Cross-platform System for Data Extraction and Visualization of Multiple Reaction Monitoring Experiments. Molecular & Cellular Proteomics. 7(11). 2270–2278. 69 indexed citations

14.

Prakash, Amol, Brian Piening, Heidi Zhang, et al.. (2007). Assessing Bias in Experiment Design for Large Scale Mass Spectrometry-based Quantitative Proteomics. Molecular & Cellular Proteomics. 6(10). 1741–1748. 49 indexed citations

15.

Dall’Era, Marc, Asa Oudes, Daniel B. Martin, & Alvin Y. Liu. (2007). HSP27 and HSP70 interact with CD10 in C4‐2 prostate cancer cells. The Prostate. 67(7). 714–721. 21 indexed citations

16.

Schmid, Amy, David J. Reiss, Amardeep Kaur, et al.. (2007). The anatomy of microbial cell state transitions in response to oxygen. Genome Research. 17(10). 1399–1413. 51 indexed citations

17.

Mallick, Parag, Markus Schirle, Sharon S. Chen, et al.. (2006). Computational prediction of proteotypic peptides for quantitative proteomics. Nature Biotechnology. 25(1). 125–131. 551 indexed citations breakdown →

18.

Flory, Mark R., Timothy J. Griffin, Daniel B. Martin, & Ruedi Aebersold. (2002). Advances in quantitative proteomics using stable isotope tags. Trends in biotechnology. 20(12). s23–s29. 70 indexed citations

19.

Martin, Daniel B. & Peter S. Nelson. (2001). From genomics to proteomics: techniques and applications in cancer research. Trends in Cell Biology. 11(11). S60–S65. 46 indexed citations

20.

Martin, Daniel B., et al.. (1988). Angina and ST-Segment Depression During Treadmill and Arm Ergometer Testing in Patients with Coronary Artery Disease. Physical Therapy. 68(2). 195–198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact